Michael Ryskin
Stock Analyst at B of A Securities
(1.47)
# 3,553
Out of 5,111 analysts
39
Total ratings
52%
Success rate
-1.32%
Average return
Main Sectors:
Stocks Rated by Michael Ryskin
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SDGR Schrödinger | Upgrades: Buy | $24 | $17.98 | +33.48% | 3 | Dec 15, 2025 | |
| RVTY Revvity | Maintains: Buy | $110 → $99 | $98.15 | +0.87% | 1 | Sep 22, 2025 | |
| TEM Tempus AI | Maintains: Neutral | $68 → $70 | $62.36 | +12.25% | 6 | Jun 25, 2025 | |
| IDXX IDEXX Laboratories | Maintains: Neutral | $535 → $475 | $669.99 | -29.10% | 3 | Apr 21, 2025 | |
| MRVI Maravai LifeSciences Holdings | Maintains: Buy | $9 → $8 | $3.40 | +135.29% | 3 | Mar 3, 2025 | |
| ALGN Align Technology | Maintains: Underperform | $200 → $206 | $156.03 | +32.03% | 6 | Dec 13, 2024 | |
| GH Guardant Health | Maintains: Buy | $28 → $40 | $101.74 | -60.68% | 1 | Jul 18, 2024 | |
| ALIT Alight | Maintains: Buy | $10 → $9.5 | $1.88 | +405.32% | 1 | Jun 25, 2024 | |
| CERT Certara | Maintains: Buy | $27 → $24 | $8.74 | +174.60% | 2 | Aug 15, 2023 | |
| AVTR Avantor | Maintains: Buy | $27 → $24 | $11.46 | +109.42% | 2 | Jul 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $225 → $180 | $125.92 | +42.95% | 7 | Nov 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $4.20 | - | 2 | Apr 18, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | $17 → $10 | $3.61 | +177.01% | 2 | Nov 10, 2021 |
Schrödinger
Dec 15, 2025
Upgrades: Buy
Price Target: $24
Current: $17.98
Upside: +33.48%
Revvity
Sep 22, 2025
Maintains: Buy
Price Target: $110 → $99
Current: $98.15
Upside: +0.87%
Tempus AI
Jun 25, 2025
Maintains: Neutral
Price Target: $68 → $70
Current: $62.36
Upside: +12.25%
IDEXX Laboratories
Apr 21, 2025
Maintains: Neutral
Price Target: $535 → $475
Current: $669.99
Upside: -29.10%
Maravai LifeSciences Holdings
Mar 3, 2025
Maintains: Buy
Price Target: $9 → $8
Current: $3.40
Upside: +135.29%
Align Technology
Dec 13, 2024
Maintains: Underperform
Price Target: $200 → $206
Current: $156.03
Upside: +32.03%
Guardant Health
Jul 18, 2024
Maintains: Buy
Price Target: $28 → $40
Current: $101.74
Upside: -60.68%
Alight
Jun 25, 2024
Maintains: Buy
Price Target: $10 → $9.5
Current: $1.88
Upside: +405.32%
Certara
Aug 15, 2023
Maintains: Buy
Price Target: $27 → $24
Current: $8.74
Upside: +174.60%
Avantor
Jul 31, 2023
Maintains: Buy
Price Target: $27 → $24
Current: $11.46
Upside: +109.42%
Nov 4, 2022
Maintains: Buy
Price Target: $225 → $180
Current: $125.92
Upside: +42.95%
Apr 18, 2022
Downgrades: Neutral
Price Target: n/a
Current: $4.20
Upside: -
Nov 10, 2021
Downgrades: Underperform
Price Target: $17 → $10
Current: $3.61
Upside: +177.01%